RECORDATI

RECORDATI

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related pr... oducts, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. is a subsidiary of Fimei - Finanziaria Industriale Mobiliare ed Immobiliare S.P.A.

Recordati_logo

Industry:
Organization

Founded:
1926

Address:
Via Matteo Civitali 1, Milan, MI, Italy Zipcode 20148

Country:
Italy

Phone:
39 02 487871

Company Size Range:
1001 - 5000
Current Employees:
655
Total Employees:
1,499

Market Cap:
9.38B
Total Revenue:
1.45B
Total Assets:
2.71B
Total Cash:
188.23M


Key Executives
Name Title Pay Year Born
Mr. Andrea Recordati CEO & Director N/A 1971(49 years old)
Mr. Fritz Squindo Group GM & Exec. Director N/A 1956(64 years old)
Mr. Luigi Felice La Corte Group Chief Financial Officer N/A 1969(51 years old)
Ms. Federica De Medici Director of Investor Relations & Corp. Communications N/A N/A
Ms. Daria Ghidoni VP of Corp. Legal Counsel N/A N/A
Mr. Gabriele Finzi VP of Corp. Devel. & Licensing N/A N/A
Mr. Giuseppe Gualazzini Sr. VP of Group HR N/A 1959(61 years old)
Mr. Corrado Castellucci Exec. VP of Rare Diseases Bus. Unit N/A N/A
Ms. Luisa Mainoli Sr. VP of Group Fin. N/A N/A
Mr. Roberto Teruzzi Exec. VP of Group Industrial Operations N/A N/A



Financial & Stock
Exchange Milan. Currency in EUR. Market state PREPRE
According to Recordati's financial reports the company's revenue in 2020 were 1.45B an decrease(0%) over the years 2019 revenue that were of 1.48B. In 2020 the company's total earnings were 354.98M while total earnings in 2019 were 368.82M(-3.8%).
Company's stock symbol is REC.MI. Lastest price : 45.46. Total volume :323.81k Click reload if you want to check the lastest price on market!!!


Site Inspections: http://www.recordati.com

Unable to get host informations!!!

Loading ...
Loading ...


More informations about "Recordati" on Search Engine

Recordati S.p.A - Home

Recordati.com Company data RECORDATI S.p.A. VIA M. CIVITALI, 1 - 20148 MILAN, ITALY SHARE CAPITAL € 26.140.644,5 i.v. REG. IMP. MILANO, MONZA, BRIANZA e LODI 00748210150 CODICE FISCALE/P. IVA 00748210150 R.E.A. MILANO 401832 Company subject to the Management and Coordination Activities of Rossini Luxembourg S.àr.l delivered by Tech Style

Recordati S.p.A - Home

Recordati.com Recordati Rare Diseases is dedicated to the research, development and marketing of …

Recordati S.p.A - Home

Recordati.com Company data RECORDATI S.p.A. VIA M. CIVITALI, 1 - 20148 MILAN, ITALY SHARE …

Recordati S.p.A - Home

Recordati.com The legal affairs office verifies and prepares the Recordati group contracts, be they of a …

Recordati S.p.A - Home

Recordati.com Recordati is a partner of choice for new product licenses for its territories. Recordati is …

Recordati S.p.A - Home

Recordati.com 24 march 2021 recordati: isturisa® (osilodrostat) approved in japan 23 march …

Recordati S.p.A - Home

Recordati.com Andrea Recordati gained a Bachelor of Arts in medieval and modern history from the …

Recordati S.p.A - Home

Recordati.com Recordati markets both proprietary products as well as innovative drugs under license from …

Recordati S.p.A - Home

Recordati.com 1926 Recordati was founded in Correggio (Emilia, Italy) as “Laboratorio …

Recordati S.p.A - Home

Recordati.com About Us > Contacts - Recordati S.p.A - Home

Home | Recordati Rare Diseases

Recordatirarediseases.com RECORDATI: POSITIVE RESULTS FROM THE PHASE III LINC-4 STUDY PRESENTED AT THE ENDOCRINE SOCIETY’S ANNUAL MEETING REINFORCE THE EFFICACY AND SAFETY OF ISTURISA® (OSILODROSTAT) IN CUSHING’S DISEASE. 03/23/2021 Shortage of DESOXYN (methamphetamine hydrochloride tablets, USP) 5mg. 02/26/2021 ...

Home | Recordati Rare Diseases

Recordatirarediseases.com Recordati Rare Diseases is committed to the well being of patients living with rare diseases. It’s our first priority to help protect the safety and lives of patients around the world. We will continue to endeavor maintaining a constant supply of our critical care products. Please contact us …

Recordati – CVC

Cvc.com Recordati Donating medication across Europe for COVID-19 patients. Italian-based international pharmaceutical group Recordati is one of the world's most active companies in the field of research, development and marketing of treatments for rare diseases. Since the coronavirus pandemic started, Recordati has diverted medicines and funds with a ...

RECORDATI: LICENSE OBTAINED FOR THE COMMERCIALIZATION …

Markets.businessinsider.com Jan 29, 2021 · Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new specialties with a …

Recordati S.p.A - Home

Recordati.it Dati societari RECORDATI S.p.A. VIA M. CIVITALI, 1 - 20148 MILANO, ITALIA CAPITALE SOCIALE € 26.140.644,5 i.v. REG. IMP. MILANO, MONZA, BRIANZA e LODI 00748210150 CODICE FISCALE/P. IVA 00748210150 R.E.A. MILANO 401832 Società Soggetta all’attività di Direzione e Coordinamento di Rossini Luxembourg S.à r.l delivered by Tech Style

Working at Recordati | Glassdoor

Glassdoor.com Nov 12, 2017 · Glassdoor gives you an inside look at what it's like to work at Recordati, including salaries, reviews, office photos, and more. This is the Recordati company profile. All content is posted anonymously by employees working at Recordati.

Recordati ilaç San.ve Tic. A.Ş.

Recordati.com.tr Recordati S.p.A, merkezi İtalya’da olan, başlıca Avrupa ülkeleri ve Türkiye’de operasyonları bulunan ve Orta ve Doğu Avrupa’nın yeni pazarlarında büyüyen varlığıyla Avrupalı bir ilaç grubudur.Recordati araştırma ve geliştirme yatırımlarını, kardiyovasküler ve üroloji alanlarında ve nadir hastalıkların tedavisinde yapmaktadır.

CVC buys majority of drugmaker Recordati, to launch

Reuters.com A consortium of investment funds controlled by CVC Capital Partners has agreed to buy 51.8 percent of Italian pharmaceutical group Recordati in a deal worth about 3 billion euros ($3.5 ...

RECORDATI: POSITIVE RESULTS FROM THE PHASE III LINC 4

Finance.yahoo.com Mar 23, 2021 · Recordati is committed to the research and development of new specialties with a focus on treatments for rare diseases. Consolidated revenue for 2020 was € …

RECORDATI: Recordati Rare Diseases now holds Isturisa

Bloomberg.com Apr 08, 2020 · Recordati is committed to the research and development of new specialties with a focus on treatments for rare diseases. Consolidated revenue for 2019 was € …

RECORDATI ORD (REC.MI) Stock Price, News, Quote & History

Finance.yahoo.com Recordati is committed to the research and development of new specialties, with a focus on treatments for rare diseases. Consolidated revenue for 2019 was € 1,481.8 million, operating income was ...

Recordati: Positive Results From the Phase III LINC-4

Businesswire.com Mar 23, 2021 · Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new specialties with a …

PANHEMATIN® (hemin for injection) Official Treatment Website

Panhematin.com Recordati Rare Diseases does not control the opinions, claims or comments contained on any third-party website linked to PANHEMATIN.com, and your activities at those websites will be governed by the policies and practices of those third parties.

CVC Fund VII acquires controlling stake in Recordati S.p.A

Cvc.com Jun 29, 2018 · The Recordati family requested, and the Consortium has agreed, to provide other shareholders with a full cash offer at €28.00 per share, which implies a higher economic value than the cash and deferred payment made to the Recordati family. The offer of the full price in cash to the minority shareholders in the MTO is subject to the absence of ...

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA IN BREVE

Dnb.com Recordati's products are distributed in some 100 countries. Key Principal. ALFREDO ALTAVILLA See more contacts. Industry. Pharmaceutical Manufacturing Manufacturing Sector Medicinals and botanicals Food preparations, nec Distilled and blended liquors Bottled and canned soft drinks Toilet preparations Chemical preparations, nec See all industries.

RECORDATI : REC Stock Price | IT0003828271 | MarketScreener

Marketscreener.com Recordati specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (83.1%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (16.9%).

RECORDATI: MERGER BY ABSORPTION OF FIMEI S.P.A. AND

Globenewswire.com Oct 01, 2020 · As a result of the merger, the shareholdings in Recordati S.p.A. of Rossini S.à r.l. (indirectly held by CVC Capital Partners VII Limited), currently equal to 51.820% of Recordati S.p.A.’s ...

Recordati : 2020 Preliminary FY results - 2021 Targets

Marketscreener.com Recordati S.p.A. published this content on 22 February 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 February 2021 14:38:02 UTC.

What Does Recordati Make? | Sunrise House

Sunrisehouse.com Aug 15, 2019 · Recordati helps to develop and market many pharmaceutical products in specialty fields of healthcare, including for rare diseases. Desoxyn (Methamphetamine) Available via Prescription. Another product marketed by the Recordati Rare Diseases group is Desoxyn, which is a prescription and tablet form of methamphetamine.

RECORDATI AG Company Profile | Baar, ZUG, Switzerland

Dnb.com RECORDATI AG is located in Baar, ZUG, Switzerland and is part of the Drug Wholesalers Industry. RECORDATI AG has 5 employees at this location and generates $1.32 million in sales (USD). There are 3 companies in the RECORDATI AG corporate family.

RECORDATI: POSITIVE RESULTS FROM THE PHASE III LINC 4

Markets.businessinsider.com Mar 23, 2021 · Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, …

Recordati Reviews | Glassdoor

Glassdoor.com Jun 26, 2019 · 5 Recordati reviews. A free inside look at company reviews and salaries posted anonymously by employees.

Recordati: ISTURISA® (osilodrostat) Phase III LINC-4 Trial

Businesswire.com Jun 17, 2020 · Recordati Rare Diseases is a part of the Recordati Group, a public international specialty pharmaceutical company committed to the research and development of new …

REC:BrsaItaliana Stock Quote - Recordati Industria Chimica

Bloomberg.com Recordati Industria Chimica e Farmaceutica S.p.A., doing business as Recordati SpA, manufactures pharmaceuticals. The Company researches, develops, manufactures, and markets prescription and …

Recordati: A Somehow Boring But Interesting Pharmaceutical

Seekingalpha.com Summary. Recordati is a defensive healthcare company with a strong cash generation and a robust balance sheet. Its strategic shift from a traditional pharmaceutical company towards a more rare ...

Recordati Company Profile: Stock Performance & Earnings

Pitchbook.com Recordati General Information Description. Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth strategy.

Recordati: Positive Results From the Phase III LINC-4

Apnews.com Mar 23, 2021 · Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new specialties with a focus on treatments for rare diseases. Consolidated revenue for 2020 was €1448.9 million, operating income was €469.0 million, and net income was €355.0 million.

Pasireotide - RECORDATI - AdisInsight

Adisinsight.springer.com 12 Jul 2019 Recordati enters into an agreement with Novartis to acquire Pasireotide ; Subscriber content You need to be a logged in subscriber to view this content. If your organization has a subscription then there are several options available to help you access AdisInsight, even while ...

Recordati AG – Swiss Biotech

Swissbiotech.org Recordati is an international pharmaceutical group, listed on the Italian Stock Exchange dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations throughout the whole of Europe, North and South Amercia and Asia.

Recordati: Isturisa® (Osilodrostat) Approved In The U.S.

Prnewswire.com Recordati Rare Diseases Inc. is a part of the rare disease business within the Recordati Group, a public international specialty pharmaceutical company committed to the research and development of ...

RECORDATI - Overview, News & Competitors | ZoomInfo.com

Zoominfo.com Jan 01, 2007 · View RECORDATI (www.recordati.com) location in Lombardy, Italy , revenue, industry and description. Find related and similar companies as well as employees by title and much more.

RECORDATI: POSITIVE RESULTS FROM THE PHASE III LINC 4

Apnews.com Mar 23, 2021 · Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new specialties with a focus on treatments for rare diseases. Consolidated revenue for 2020 was € 1,448.9 million, operating income was € 469.0 million and net income was € 355.0 million.

Recordati S.p.A. | LinkedIn

Linkedin.com Recordati S.p.A. | 41,563 followers on LinkedIn. Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM ...

PharmaBoardroom | Recordati Ireland

Pharmaboardroom.com Recordati is a European specialty pharmaceutical group dedicated to partnering, discovering and developing innovative, value-added products that improve the quality of life and help people to enjoy longer, healthier and more productive lives.

Recordati Competitors, Reviews, Marketing Contacts

Media-index.kochava.com Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of more than 4,100, dedicated to the research, development, manufacturing and marketing of pharmaceuticals.

Recordati - Crunchbase Company Profile & Funding

Crunchbase.com Jul 14, 2016 · Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of over 3,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals.

Recordati: Isturisa® (Osilodrostat) Approved In The U.S

Biospace.com Mar 09, 2020 · Recordati is committed to the research and development of new specialties with a focus on treatments for rare diseases. Consolidated revenue for 2019 was € 1,481.8 million, operating income was € 465.3 million and net income was € 368.9 million. Recordati website: www.recordati.com

REC Stock Price | Recordati S.p.A. Stock Quote (Italy)

Marketwatch.com Mar 25, 2021 · Recordati S.p.A. Recordati SpA engages in the research, development, manufacturing and marketing of pharmaceuticals. It operates through …

UPDATE 1-Recordati names new CEO after death of Giovanni

Reuters.com Recordati, shifting its primary care business towards higher margin specialty medicines, could be an attractive target for a laboratory seeking a foothold or stronger presence in Europe, analysts ...

Recordati - SAP Concur

Concur.com Recordati streamlined the end-to-end invoice management process by deploying Concur Invoice, resulting in time savings of 50%. Recordati Rare Diseases Inc. (RRD) is a biopharmaceutical company committed to providing often overlooked orphan therapies to the underserved rare disease communities of the United States.

Recordati and Novartis' Isturisa Approved for Cushing's

Biospace.com Mar 09, 2020 · Recordati acquired the drug from Novartis in June 2019. Isturisa is the first drug approved that blocks an enzyme called 11-beta-hydroxylase, preventing synthesis of cortisol. The disease is caused by a pituitary tumor that releases excess amounts of a hormone called adrenocorticotropin.

Recordati Rare Diseases: Positive Results From the Phase

Streetinsider.com Recordati is committed to the research and development of new specialties with a focus on treatments for rare diseases. Consolidated revenue for 2020 was € 1,448.9 million, operating income was ...

RCDTF Stock Forecast, Price & News (Recordati Industria)

Marketbeat.com Recordati Industria Chimica e Farmaceutica has received 54.87% “underperform” votes from our community. MarketBeat's community ratings are surveys of what our community members think about Recordati Industria Chimica e Farmaceutica and other stocks. Vote “Outperform” if you believe RCDTF will outperform the S&P 500 over the long term.

RCDTF Company Profile & Executives - Recordati S.p.A

Wsj.com Guido Guidi Vice Chairman, Recordati SpA. Currently, Guido Guidi occupies the position of Managing Director at Geleven SRL. He is also Member of Italfarmaco SpA and on the board of 6 other companies.

Recordati Rare Diseases, Inc 100 Corporate Dr Lebanon, NJ

Mapquest.com Recordati Rare Diseases, Inc 100 Corporate Dr Lebanon NJ 08833. Reviews (908) 840-4631 Website. Menu & Reservations Make Reservations . Order Online Tickets Tickets See Availability Directions {{::location.tagLine.value.text}} Sponsored Topics. Legal. Help. Get directions, reviews and information for Recordati Rare Diseases, Inc in Lebanon, NJ. ...